Lornamed (Lornoxicam)

Lornamed is a pharmaceutical product containing Lornoxicam, a potent non-steroidal anti-inflammatory drug (NSAID) belonging to the oxicam class. It is primarily used for the management of acute mild-to-moderate pain and the symptomatic treatment of pain and inflammation in osteoarthritis and rheumatoid arthritis.

The manufacturing of Lornamed involves various pharmaceutical production sites worldwide to meet regional healthcare demands, often produced by licensed pharmaceutical facilities in regions like the Middle East and Southeast Asia. The brand was originally developed by pharmaceutical innovators focusing on analgesics.

Today, the brand is managed by specialized pharmaceutical corporations that oversee its distribution and quality control across international markets. Its ownership typically lies with companies dedicated to manufacturing high-quality generic and branded medications, ensuring accessibility to essential pain management treatments across diverse global health systems.